Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-08-14
1995-01-31
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A01K 31425
Patent
active
053859219
ABSTRACT:
New pharmaceutical formulations comprising 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole or optical isomers or a pharmaceutically acceptable salt or solvate thereof.
REFERENCES:
patent: 4212709 (1980-07-01), Patsch et al.
M. Ende, et al., Urinary Metabolites of Clomethiazole, Arzneim-Forsch/Drug. Res. 29(II) Nr. 11, pp. 1655-1658 (1979).
R. Pal, et al., Thiomethylation and Thiohydroxylation-A New Pathway of Metabolism of Heterocyclic Compounds, Xenobiotica, vol. 12, No. 12, pp. 813-820 (1982).
C. P. Offen, et al., 4,5-Dimethylthiazole-N-Oxide-S-Oxide; A Metabolite of Chlormethiazole In Man, Xenobiotica, vol. 15, No. 6, pp. 503-511 (1985).
A. R. Green, et al., A simple Intravenous Infusion Method In Rodents for Determining the Potency of Anticonvulsants Acting Through GABAergic Mechanisma, J. Pharm. Pharmacol. 41; 879-800 (1989).
Goodman and Gilman's The Pharmacological Basis of Therapeutics Seventh Edition, pp. 13, 357, 454 and 455 (1985).
D. V. Parke, Recent Advances in Pharmacology, 4th Ed., p. 68, (1968) reprinted In Taylor et al. Introductory Medicinal Chemistry, p. 182.
Alfred Burger, A Guide To The Chemical Basis of Drug Design, p. 137 (1983).
Paul L. Ornstein, et al., Synthesis and Pharmacology of A Series of 3- and 4-(Phosphonoalkyl)Pyridine-and -Piperiding-2-Carboxylic Acids. Potent N-Methyl-D-Aspartate Receptor Antagonists, J. Med. Chem. 32, 827 (1989).
C. W. Cotman et al., Excitatory Amino Acids In The Brain-Focus On NMDA Receptors, TINS, vol. 10, No. 7, pp. 263-265 (1987).
William F. Maragos, et al., Glutamate dysfunction in Alzheimer's disease: an hypothesis, TINS 10, 65-68 (1987).
N. T. Gurusinghe, et al., Chlormethiazole In The Management Of Post-Cranitomy Seizures, Acta. Psychiatr. Scand. Suppl. 329, vol. 73, pp. 189-193 (1986).
S. A. Ather, et al., A Comparison of Chlormethiazole and Thioridazine In Agitated Confusional States of the Elderly, Acta. Phychiatr. Scand. Suppl. 329, vol. 73, pp. 81-91 (1986).
T. V. Stanley, Oral Chlormethiazole in Childhood Epilepsy, Archives of Disease in Childhood, vol. 57, pp. 242-3 (1982).
Louis Low et al., Prolonged Intravenous Use of Chlormethiazole (Heminevrin), British Medical Journal, p. 484 (1980).
F. Nouailhat et al., abstract of Treatment of Status Epilepticus In The Adult, Rev. Electroencephalogr. Neurophysiol Clin. 14, 237 (1985).
C. Carlsson et al., Influence of Chlormethiazole On Cerebral Blood Flow and Oxygen Consumption In The Rat, and Its Effect on the Recovery Of Cortical Energy Metabolism After Pronounced, Incomplete Ischaemia, Acta. Anaesth. Scand. 23, 259-266 (1979).
I. Piehlmayr et al., Studies On Blood Flow, Metabolism and Autoreglation Of The Brain Under Chlormethiazol(Distraneurin.RTM.) In Animal Experiments, Annesthesist. 22, 496-500 (1973).
M. G. Mead et al., Confusion And Hypnotics In Demented Patients, Journal Of The Royal College Of General Practitioners 32, 763-765 (1982).
Boar Bernard R.
Cross Alan J.
Green Alfred R.
Hagberg Curt-Eric
Aktiebolaget Astra
Gerstl Robert
LandOfFree
Pharmaceutical formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1102424